Nathalie Gros
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Synthesis and in vitro inhibitory activity of N-arylsulfonamide adenosine analogues designed to target SARS-CoV-2 nsp14 N7-methyltransferase.
Journal: Bioorganic chemistry
Published: July 22, 2025
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches.
Journal: Emerging microbes & infections
Published: November 25, 2024
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2.
Journal: RNA biology
Published: June 05, 2023
The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2.
Journal: International journal of molecular sciences
Published: May 23, 2023
Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies.
Journal: Frontiers in microbiology
Published: April 06, 2023
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
Journal: The British journal of dermatology
Published: May 30, 2022
Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.
Journal: Scientific reports
Published: December 09, 2021
The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses.
Journal: EMBO reports
Published: September 28, 2021
Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.
Journal: Scientific reports
Published: March 11, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026